Nitre, Liezel N.

HRN: 23-62-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
DOXYCYCLINE 100MG (CAP)
10/20/2023
10/27/2023
PO
100mg
BID X 7 Days
Cervical CA; PID
Waiting Final Action 
10/20/2023
DOXYCYCLINE 100MG (CAP)
10/20/2023
10/27/2023
PO
100mg
BID X 7 Days
Cervical CA; PID
Waiting Final Action 
10/20/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/20/2023
10/27/2023
IVT
900mg
Q8
Cervical CA; PID
Waiting Final Action 
10/20/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/20/2023
10/27/2023
IVT
900mg
Q8
Cervical CA; PID
Waiting Final Action 
10/20/2023
CEFTRIAXONE 1G (VIAL)
10/20/2023
10/20/2023
IM
1g
Single Dose
Cervical CA; PID
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: